Variable | Description |
---|---|
Clinical | |
ALSFRS-R score (ALSFRS-R) | ALS Functional Rating Scale Revised consists of 12 questions, each scored out of 4 points. A total score is calculated by summing the scores from each question with a maximum score of 48 (better performance, i.e., absence of the measured symptoms of ALS) and a minimum score of 0 (worst performance) |
Survival time measured by death or respiratory insufficiency | Survival status is recorded at the end of study as well as respiratory insufficiency defined as tracheostomy or the use of non-invasive ventilation for ≥ 22 h per day for ≥ 10 consecutive days. Survival time is defined as the time elapsed between randomization and death from any cause and tracheostomy, whichever occurs first |
Forced vital capacity score (FVC) | The index of respiratory function expressed as a percentage of the expected value is used to indicate potential respiratory compromise |
Muscle force assessed by the Medical Research Council (MRC) scale | MRC score is a summation of the strength of 6 muscle groups tested on both sides ranging from 0 (paralysis) to 60 (normal strength) |
Health-related quality of life | |
Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) | ALSAQ-40 score is a patient self-report health status PRO based on 40 questions specifically used to measure the subjective well-being of patients with ALS in a scale from 0 (best possible health status) to 100 (worst possible) |
EQ-5D scale score (EQ-5D-5L) | The 5-level EQ-5D version is a self- assessed health-related quality of life (HRQoL) questionnaires based on 5 questions ranging from 0 (worst health) to 100 (best health) |
Biomarker | |
Creatinine level | Plasma creatinine is a breakdown product of creatine phosphate and it is related to muscle mass, expressed in μmol/L or micromol/L |
Neurofilament level | Value of neurofilaments (light chain and phosphorylated heavy chain) in the CSF and serum resulting as a mean from triplicate measurements expressed in pg/ml |
MMP-9 expression | The expression of matrix metalloproteinase-9 in serum is a mean of at least two duplicates, expressed in pg/ml |